Bolt Biotherapeutics, Inc. - stock earnings
BOLT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.3 million USD | 2.5 million USD |
| 2023Q2 | -18.1 million USD | 1.4 million USD |
| 2023Q1 | -15.5 million USD | 1.8 million USD |
| 2022Q4 | -19.0 million USD | 1.4 million USD |
| 2022Q3 | -21.2 million USD | 2.1 million USD |
| 2022Q2 | -22.3 million USD | 1.4 million USD |
| 2022Q1 | -23.5 million USD | 813000 USD |
| 2021Q4 | -27.2 million USD | 508000 USD |
| 2021Q3 | -23.4 million USD | 752000 USD |
| 2021Q2 | -23.6 million USD | ? USD |
| 2021Q1 | -24.5 million USD | 231000 USD |
| 2020Q4 | -31.0 million USD | 231000 USD |
| 2020Q3 | -10.0 million USD | ? USD |
| 2020Q2 | -11.1 million USD | 67000 USD |
| 2020Q1 | -8.6 million USD | 164000 USD |
| 2019Q4 | -9.4 million USD | 65000 USD |
BOLT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -71.3 million USD | 7.2 million USD |
| 2022 | -85.9 million USD | 5.7 million USD |
| 2021 | -104.4 million USD | 1.3 million USD |
| 2020 | -72.3 million USD | 231000 USD |
| 2019 | -30.0 million USD | 215000 USD |
| 2018 | -11.6 million USD | ? USD |
BOLT
Price: $1.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.58
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 121100
Market Capitalization: 50.3 million
Average Dividend Frequency: 4